{"id":"W3009747441","doi":"10.3747/co.27.5347","title":"Biopsy on Progression in Patients with EGFR Mutation–Positive Advanced Non-Small-Cell Lung Cancer—A Canadian Experience","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada); BC Cancer Foundation; BC Cancer Agency; Spinal Cord Injury BC; Alberta Health Services","funders":"","keywords":"Medicine; T790M; Osimertinib; Lung cancer; Erlotinib; Internal medicine; Oncology; Biopsy; Retrospective cohort study; Cancer; Mutation; Epidermal growth factor receptor; Pathology; Gefitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001609762,0.0004467934,0.0004145363,0.0008642367,0.001842466,0.000796355,0.0007192598,0.0004747411,0.001418927],"category_scores_gemma":[0.002745958,0.0002657021,0.0003517639,0.001648961,0.0009407121,0.0003270432,0.0006125067,0.0008653608,0.0001904727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00977076,"about_ca_system_score_gemma":0.01604792,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7510969,"about_ca_topic_score_gemma":0.8471696,"domain_scores_codex":[0.9990937,0.0001619256,0.00004129145,0.000131263,0.0003756677,0.0001961804],"domain_scores_gemma":[0.9980133,0.0001931662,0.0002326109,0.00007445482,0.0008620053,0.0006245737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002106238,0.0003799493,0.892418,0.0004172945,0.0001175879,0.007011797,0.002919331,0.0003582013,0.005241788,0.0002170467,0.003204427,0.08560833],"study_design_scores_gemma":[0.0001604026,0.001409505,0.9742261,0.0001825486,0.0001170475,0.009942739,0.002655856,0.0004259462,0.001206102,0.00006931221,0.009561748,0.00004275279],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827142,0.009408327,0.0003861711,0.0006367134,0.00006329099,0.0003589805,0.0004312002,0.00001811552,0.005982989],"genre_scores_gemma":[0.9913822,0.006236432,0.0007397606,0.0003603606,0.00004673824,0.000035498,0.0004094667,0.00001135829,0.0007783127],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2489031,"threshold_uncertainty_score":0.5007378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02544159754967788,"score_gpt":0.398278013277729,"score_spread":0.3728364157280511,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}